Developer of novel therapies based in Vienna, Austria. The company offers discovery related to tissue degeneration diseases, which is caused by a pathological process affecting the integrity and decreasing the functionality of tissues and organs.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Seed Round | 04-Mar-2020 | Completed | Generating Revenue |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
ARAX Capital Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
Kinled Holding | Venture Capital | Minority | 000 0000 | 000000 0 | |
Life Link Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
Olipan Investments | Venture Capital | Minority | 000 0000 | 000000 0 | |
The Blom Family Office | Family Office | Minority | 000 0000 | 000000 0 |